Clinical trial
Angiotensin II Blockade for Chronic Allograft Nephropathy
NCT00067990 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00067990 |
|---|---|
| Title | Angiotensin II Blockade for Chronic Allograft Nephropathy |
| Official title | Angiotensin II Blockade for the Prevention of Cortical Interstitial Expansion and Graft Loss in Kidney Transplant Recipients |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Disease, Proteinuria |
| Intervention type | Drug |
| Interventions | Losartan 100mg, Placebo |
| Enrollment | 153 |
| Start date | Dec 1, 2002 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Sep 5, 2003 |
| Last update posted | Sep 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: